Print Page | Sign In | Join FSN
News & Press: News & Updates

Urgent Regulatory Alert for Nephrologists in Florida

Tuesday, June 26, 2018   (0 Comments)
Posted by: Diane Berg
Share |
The FSN leadership wants to make sure that all of our members are prepared for implementation of HB 21 - Controlled Substances. The legislation goes into effect on July 1st.  While the prescription limitations in the bill are targeted to Schedule II opioids for the treatment of acute pain, there are other requirements in the bill that will impact most physicians in the state. Please do not think this legislation only impacts opioids.
 
Here are the specific measures that will impact a number of our members:
 
  1. As of July 1, any health care practitioner that prescribes any scheduled drug must check the patient’s drug history in Florida's Prescription Drug Monitoring Database (E-FORCSE) prior to writing that script. This mandate is not limited to opioids. It is for all scheduled drugs. The only exemptions are for children under the age of 16 and for Schedule V non-opioids. 
  2. Every Health Care Practitioner that has a DEA license to prescribe controlled substances must take an approved 2-hour CME course on Controlled Substances by January 31, 2019. 
  3. As of July 1, all prescriptions for Schedule II opioids to treat “Acute Pain” are limited to a 3-day supply.  Physicians can prescribe up to a 7-day supply if certain conditions are met.
 
The FSN recorded a webinar and has provided a number of resources that are available on our website:  www.floridasocietyofnephrology.com/page/HB21
 
You should also reference the Florida Department of Health website for more information. This is the definitive source for regulation of this legislation: http://www.flhealthsource.gov/FloridaTakeControl/
 
Thank you very much for your attention and awareness of the impact of this legislation.   

FLORIDA SOCIETY OF NEPHROLOGY
1215 E. Robinson Street, Orlando, FL 32801
Phone: 813-909-0450  |  Fax: 813-949-8994